Literature DB >> 7961967

Serine 1524 is a major site of phosphorylation on human topoisomerase II alpha protein in vivo and is a substrate for casein kinase II in vitro.

N J Wells1, C M Addison, A M Fry, R Ganapathi, I D Hickson.   

Abstract

Topoisomerase II protein is essential for cell proliferation and is known to exist as a phosphoprotein in cells from both lower and higher eukaryotic species. In this paper, we have investigated the phosphorylation of the alpha isozyme of human topoisomerase II. The topoisomerase II alpha protein was phosphorylated predominantly on serine residues in the human tumor cell lines HeLa and NSCLC-3. Two-dimensional tryptic phosphopeptide mapping studies revealed several sites of phosphorylation in vivo, including a major site that was common to topoisomerase II alpha protein from both HeLa and NSCLC-3 cells. To identify sites of phosphorylation, the regulatory C-terminal domain of human topoisomerase II alpha protein was overexpressed in Escherichia coli as a hexahistidine-tagged fusion protein and purified by nickel chelate chromatography. Tryptic phosphopeptide mapping revealed that casein kinase II phosphorylated the C-terminal domain primarily on 2 serine residues in vitro, which were shown to be sites of modification in vivo. Site-directed mutagenesis studies identified these casein kinase II-specific phosphorylation sites as serine 1524 and serine 1376.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961967

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Mutations in the C-terminal domain of topoisomerase II affect meiotic function and interaction with the casein kinase 2 beta subunit.

Authors:  D Leroy; G C Alghisi; E Roberts; O Filhol-Cochet; S M Gasser
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Mitosis-specific MPM-2 phosphorylation of DNA topoisomerase IIalpha is regulated directly by protein phosphatase 2A.

Authors:  Alexandre E Escargueil; Annette K Larsen
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

3.  Tyrosine 656 in topoisomerase IIβ is important for the catalytic activity of the enzyme: Identification based on artifactual +80-Da modification at this site.

Authors:  Adrian G Grozav; Belinda B Willard; Toshiyuki Kozuki; Kenichi Chikamori; Marius A Micluta; Andrei-Jose Petrescu; Michael Kinter; Ram Ganapathi; Mahrukh K Ganapathi
Journal:  Proteomics       Date:  2011-01-31       Impact factor: 3.984

4.  Mapping of topoisomerase II alpha epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis.

Authors:  B Grigolo; I Mazzetti; R M Borzì; I D Hickson; M Fabbri; L Fasano; R Meliconi; A Facchini
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

5.  Multiomics Reveals Ectopic ATP Synthase Blockade Induces Cancer Cell Death via a lncRNA-mediated Phospho-signaling Network.

Authors:  Yi-Wen Chang; Chia-Lang Hsu; Cheng-Wei Tang; Xiang-Jun Chen; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  Mol Cell Proteomics       Date:  2020-08-11       Impact factor: 5.911

6.  Extracellular signal-regulated kinase activates topoisomerase IIalpha through a mechanism independent of phosphorylation.

Authors:  P S Shapiro; A M Whalen; N S Tolwinski; J Wilsbacher; S J Froelich-Ammon; M Garcia; N Osheroff; N G Ahn
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 7.  SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.

Authors:  Ming-Ta Lee; Jeff Bachant
Journal:  DNA Repair (Amst)       Date:  2009-02-20

8.  Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.

Authors:  A Kathleen McClendon; Amanda C Gentry; Jennifer S Dickey; Marie Brinch; Simon Bendsen; Anni H Andersen; Neil Osheroff
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

9.  Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalpha.

Authors:  M Aoyama; D R Grabowski; G R Dubyak; A I Constantinou; L A Rybicki; R M Bukowski; M K Ganapathi; I D Hickson; R Ganapathi
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

10.  Topoisomerase IIalpha controls the decatenation checkpoint.

Authors:  Kuntian Luo; Jian Yuan; Junjie Chen; Zhenkun Lou
Journal:  Nat Cell Biol       Date:  2008-12-21       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.